Botulinum toxin treatment of upper esophageal sphincter hyperfunction

2004 ◽  
Vol 15 (2) ◽  
pp. 107-109 ◽  
Author(s):  
Lucian Sulica ◽  
Andrew Blitzer
2005 ◽  
Vol 26 (3) ◽  
pp. 157-162 ◽  
Author(s):  
Thomas Murry ◽  
Tamara Wasserman ◽  
Ricardo L. Carrau ◽  
Beatriz Castillo

2004 ◽  
Vol 18 (6) ◽  
pp. 397-399 ◽  
Author(s):  
Louis WC Liu ◽  
Mark Tarnopolsky ◽  
David Armstrong

Inclusion body myositis (IBM) is a progressive degenerative skeletal muscle disease leading to weakening and atrophy of both proximal and distal muscles. Dysphagia is reported in up to 86% of IBM patients. Surgical cricopharyngeal myotomy may be effective for cricopharyngeal dysphagia and there is one published report that botulinum toxin A, injected into the cricopharyngeus muscle using a hypopharyngoscope under general anesthesia, relieved IBM-associated dysphagia. This report presents the first documentation of botulinum toxin A injection into the upper esophageal sphincter using a flexible esophagogastroduodenoscope under conscious sedation, to reduce upper esophageal sphincter pressure and successfully alleviate oropharyngeal dysphagia in two IBM patients.


2013 ◽  
Vol 122 (2) ◽  
pp. 100-108 ◽  
Author(s):  
Elizabeth A. Kelly ◽  
Ian J. Koszewski ◽  
Safwan S. Jaradeh ◽  
Albert L. Merati ◽  
Joel H. Blumin ◽  
...  

2000 ◽  
Vol 110 (7) ◽  
pp. 1151-1156 ◽  
Author(s):  
Jürgen Alberty ◽  
Michael Oelerich ◽  
Karl Ludwig ◽  
Sabine Hartmann ◽  
Wolfgang Stoll

Sign in / Sign up

Export Citation Format

Share Document